Synergy CHC Corp. (NASDAQ: SNYR) Stock Competitors & Peer Comparison
See SNYR's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Distribution Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for SNYR and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| SNYR | $0.10 | -8.53% | 1M | -0.07 | -$1.40 | N/A |
| MCK | $869.00 | +1.44% | 101.7B | 21.28 | $40.82 | +0.38% |
| COR | $313.82 | +1.23% | 61.1B | 18.30 | $17.15 | +0.77% |
| CAH | $235.17 | +1.70% | 55.1B | 22.55 | $10.43 | +0.88% |
| ABC | $179.98 | -0.23% | 36.1B | 21.92 | $8.21 | N/A |
| HSIC | $89.77 | -0.39% | 10.2B | 16.91 | $5.31 | N/A |
| PDCO | $31.33 | +0.00% | 2.8B | 20.48 | $1.53 | +2.49% |
| PBH | $51.38 | +0.12% | 2.4B | 11.62 | $4.42 | N/A |
| OMI | $2.68 | +8.94% | 207.1M | -0.47 | -$5.69 | N/A |
| ACH | $0.95 | -13.55% | 71.7M | 1.38 | $0.68 | N/A |
Stock Comparison
McKesson Corporation (NYSE: MCK)
SNYR vs MCK Comparison August 2026
Synergy CHC Corp. (NASDAQ: SNYR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNYR stands at 1M. In comparison, MCK has a market cap of 101.7B. Regarding current trading prices, SNYR is priced at $0.10 on the NASDAQ, while MCK trades at $869.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNYR currently has a P/E ratio of -0.07, whereas MCK's P/E ratio is 21.28. In terms of profitability, SNYR's ROE is +0.91%, compared to MCK's ROE of -1.94%. Regarding short-term risk, SNYR is more volatile compared to MCK. This indicates higher risk in terms of short-term price fluctuations for SNYR.Check MCK's competition here
Cencora, Inc. (NYSE: COR)
SNYR vs COR Comparison August 2026
Synergy CHC Corp. (NASDAQ: SNYR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNYR stands at 1M. In comparison, COR has a market cap of 61.1B. Regarding current trading prices, SNYR is priced at $0.10 on the NASDAQ, while COR trades at $313.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNYR currently has a P/E ratio of -0.07, whereas COR's P/E ratio is 18.30. In terms of profitability, SNYR's ROE is +0.91%, compared to COR's ROE of +1.06%. Regarding short-term risk, SNYR is more volatile compared to COR. This indicates higher risk in terms of short-term price fluctuations for SNYR.Check COR's competition here
Cardinal Health, Inc. (NYSE: CAH)
SNYR vs CAH Comparison August 2026
Synergy CHC Corp. (NASDAQ: SNYR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNYR stands at 1M. In comparison, CAH has a market cap of 55.1B. Regarding current trading prices, SNYR is priced at $0.10 on the NASDAQ, while CAH trades at $235.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNYR currently has a P/E ratio of -0.07, whereas CAH's P/E ratio is 22.55. In terms of profitability, SNYR's ROE is +0.91%, compared to CAH's ROE of -0.60%. Regarding short-term risk, SNYR is more volatile compared to CAH. This indicates higher risk in terms of short-term price fluctuations for SNYR.Check CAH's competition here
AmerisourceBergen Corporation (NYSE: ABC)
SNYR vs ABC Comparison August 2026
Synergy CHC Corp. (NASDAQ: SNYR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNYR stands at 1M. In comparison, ABC has a market cap of 36.1B. Regarding current trading prices, SNYR is priced at $0.10 on the NASDAQ, while ABC trades at $179.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNYR currently has a P/E ratio of -0.07, whereas ABC's P/E ratio is 21.92. In terms of profitability, SNYR's ROE is +0.91%, compared to ABC's ROE of +1.06%. Regarding short-term risk, SNYR is more volatile compared to ABC. This indicates higher risk in terms of short-term price fluctuations for SNYR.Check ABC's competition here
Henry Schein, Inc. (NASDAQ: HSIC)
SNYR vs HSIC Comparison August 2026
Synergy CHC Corp. (NASDAQ: SNYR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNYR stands at 1M. In comparison, HSIC has a market cap of 10.2B. Regarding current trading prices, SNYR is priced at $0.10 on the NASDAQ, while HSIC trades at $89.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNYR currently has a P/E ratio of -0.07, whereas HSIC's P/E ratio is 16.91. In terms of profitability, SNYR's ROE is +0.91%, compared to HSIC's ROE of +0.12%. Regarding short-term risk, SNYR is more volatile compared to HSIC. This indicates higher risk in terms of short-term price fluctuations for SNYR.Check HSIC's competition here
Patterson Companies, Inc. (NASDAQ: PDCO)
SNYR vs PDCO Comparison August 2026
Synergy CHC Corp. (NASDAQ: SNYR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNYR stands at 1M. In comparison, PDCO has a market cap of 2.8B. Regarding current trading prices, SNYR is priced at $0.10 on the NASDAQ, while PDCO trades at $31.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNYR currently has a P/E ratio of -0.07, whereas PDCO's P/E ratio is 20.48. In terms of profitability, SNYR's ROE is +0.91%, compared to PDCO's ROE of +0.18%. Regarding short-term risk, SNYR is more volatile compared to PDCO. This indicates higher risk in terms of short-term price fluctuations for SNYR.Check PDCO's competition here
Prestige Consumer Healthcare Inc. (NYSE: PBH)
SNYR vs PBH Comparison August 2026
Synergy CHC Corp. (NASDAQ: SNYR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNYR stands at 1M. In comparison, PBH has a market cap of 2.4B. Regarding current trading prices, SNYR is priced at $0.10 on the NASDAQ, while PBH trades at $51.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNYR currently has a P/E ratio of -0.07, whereas PBH's P/E ratio is 11.62. In terms of profitability, SNYR's ROE is +0.91%, compared to PBH's ROE of +0.09%. Regarding short-term risk, SNYR is more volatile compared to PBH. This indicates higher risk in terms of short-term price fluctuations for SNYR.Check PBH's competition here
Owens & Minor, Inc. (NYSE: OMI)
SNYR vs OMI Comparison August 2026
Synergy CHC Corp. (NASDAQ: SNYR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNYR stands at 1M. In comparison, OMI has a market cap of 207.1M. Regarding current trading prices, SNYR is priced at $0.10 on the NASDAQ, while OMI trades at $2.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNYR currently has a P/E ratio of -0.07, whereas OMI's P/E ratio is -0.47. In terms of profitability, SNYR's ROE is +0.91%, compared to OMI's ROE of +0.63%. Regarding short-term risk, SNYR is less volatile compared to OMI. This indicates lower risk in terms of short-term price fluctuations for SNYR.Check OMI's competition here
Accendra Health, Inc. (NYSE: ACH)
SNYR vs ACH Comparison August 2026
Synergy CHC Corp. (NASDAQ: SNYR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNYR stands at 1M. In comparison, ACH has a market cap of 71.7M. Regarding current trading prices, SNYR is priced at $0.10 on the NASDAQ, while ACH trades at $0.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNYR currently has a P/E ratio of -0.07, whereas ACH's P/E ratio is 1.38. In terms of profitability, SNYR's ROE is +0.91%, compared to ACH's ROE of +0.63%. Regarding short-term risk, SNYR is less volatile compared to ACH. This indicates lower risk in terms of short-term price fluctuations for SNYR.Check ACH's competition here
Akso Health Group (NASDAQ: HX)
SNYR vs HX Comparison August 2026
Synergy CHC Corp. (NASDAQ: SNYR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNYR stands at 1M. In comparison, HX has a market cap of 53.4M. Regarding current trading prices, SNYR is priced at $0.10 on the NASDAQ, while HX trades at $2.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNYR currently has a P/E ratio of -0.07, whereas HX's P/E ratio is -1.84. In terms of profitability, SNYR's ROE is +0.91%, compared to HX's ROE of -1.07%. Regarding short-term risk, SNYR is more volatile compared to HX. This indicates higher risk in terms of short-term price fluctuations for SNYR.Check HX's competition here
111, Inc. (NASDAQ: YI)
SNYR vs YI Comparison August 2026
Synergy CHC Corp. (NASDAQ: SNYR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNYR stands at 1M. In comparison, YI has a market cap of 32.5M. Regarding current trading prices, SNYR is priced at $0.10 on the NASDAQ, while YI trades at $3.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNYR currently has a P/E ratio of -0.07, whereas YI's P/E ratio is -2.66. In terms of profitability, SNYR's ROE is +0.91%, compared to YI's ROE of +0.14%. Regarding short-term risk, SNYR is more volatile compared to YI. This indicates higher risk in terms of short-term price fluctuations for SNYR.Check YI's competition here
Wellgistics Health, Inc. (NASDAQ: WGRX)
SNYR vs WGRX Comparison August 2026
Synergy CHC Corp. (NASDAQ: SNYR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNYR stands at 1M. In comparison, WGRX has a market cap of 8.7M. Regarding current trading prices, SNYR is priced at $0.10 on the NASDAQ, while WGRX trades at $3.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNYR currently has a P/E ratio of -0.07, whereas WGRX's P/E ratio is -0.33. In terms of profitability, SNYR's ROE is +0.91%, compared to WGRX's ROE of +15.45%. Regarding short-term risk, SNYR is less volatile compared to WGRX. This indicates lower risk in terms of short-term price fluctuations for SNYR.Check WGRX's competition here
DataMEDS AI, Inc. (NASDAQ: MEDS)
SNYR vs MEDS Comparison August 2026
Synergy CHC Corp. (NASDAQ: SNYR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNYR stands at 1M. In comparison, MEDS has a market cap of 3.9M. Regarding current trading prices, SNYR is priced at $0.10 on the NASDAQ, while MEDS trades at $1.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNYR currently has a P/E ratio of -0.07, whereas MEDS's P/E ratio is N/A. In terms of profitability, SNYR's ROE is +0.91%, compared to MEDS's ROE of +15.45%. Regarding short-term risk, SNYR is more volatile compared to MEDS. This indicates higher risk in terms of short-term price fluctuations for SNYR.Check MEDS's competition here
Zynex, Inc. (NASDAQ: ZYXI)
SNYR vs ZYXI Comparison August 2026
Synergy CHC Corp. (NASDAQ: SNYR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNYR stands at 1M. In comparison, ZYXI has a market cap of 3.8M. Regarding current trading prices, SNYR is priced at $0.10 on the NASDAQ, while ZYXI trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNYR currently has a P/E ratio of -0.07, whereas ZYXI's P/E ratio is -0.05. In terms of profitability, SNYR's ROE is +0.91%, compared to ZYXI's ROE of +11.38%. Regarding short-term risk, SNYR is more volatile compared to ZYXI. This indicates higher risk in terms of short-term price fluctuations for SNYR.Check ZYXI's competition here
ZeroStack Corp. (NASDAQ: ZSTK)
SNYR vs ZSTK Comparison August 2026
Synergy CHC Corp. (NASDAQ: SNYR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNYR stands at 1M. In comparison, ZSTK has a market cap of 2M. Regarding current trading prices, SNYR is priced at $0.10 on the NASDAQ, while ZSTK trades at $1.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNYR currently has a P/E ratio of -0.07, whereas ZSTK's P/E ratio is -0.04. In terms of profitability, SNYR's ROE is +0.91%, compared to ZSTK's ROE of -3.82%. Regarding short-term risk, SNYR is more volatile compared to ZSTK. This indicates higher risk in terms of short-term price fluctuations for SNYR.Check ZSTK's competition here
Ridgetech, Inc. (NASDAQ: RDGT)
SNYR vs RDGT Comparison August 2026
Synergy CHC Corp. (NASDAQ: SNYR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNYR stands at 1M. In comparison, RDGT has a market cap of 743.3K. Regarding current trading prices, SNYR is priced at $0.10 on the NASDAQ, while RDGT trades at $0.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNYR currently has a P/E ratio of -0.07, whereas RDGT's P/E ratio is -0.02. In terms of profitability, SNYR's ROE is +0.91%, compared to RDGT's ROE of -0.04%. Regarding short-term risk, SNYR is more volatile compared to RDGT. This indicates higher risk in terms of short-term price fluctuations for SNYR.Check RDGT's competition here
Covetrus, Inc. (NASDAQ: CVET)
SNYR vs CVET Comparison August 2026
Synergy CHC Corp. (NASDAQ: SNYR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNYR stands at 1M. In comparison, CVET has a market cap of 0. Regarding current trading prices, SNYR is priced at $0.10 on the NASDAQ, while CVET trades at $20.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNYR currently has a P/E ratio of -0.07, whereas CVET's P/E ratio is -69.97. In terms of profitability, SNYR's ROE is +0.91%, compared to CVET's ROE of -0.06%. Regarding short-term risk, SNYR is more volatile compared to CVET. This indicates higher risk in terms of short-term price fluctuations for SNYR.Check CVET's competition here